OAM
INSM icon

Oppenheimer Asset Management’s Insmed INSM Stock Holding History

Oppenheimer Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41M Buy
14,725
+1,574
+12% +$242K 0.03% 501
2025
Q4 		$2.29M Sell
13,151
-2,702
-17% -$493K 0.03% 478
2025
Q3 		$2.28M Sell
15,853
-5,521
-26% -$676K 0.03% 531
2025
Q2 		$2.15M Buy
21,374
+1,439
+7% +$110K 0.02% 531
2025
Q1 		$1.52M Buy
19,935
+5,453
+38% +$417K 0.02% 608
2024
Q4 		$1,000K Buy
14,482
+33
+0.2% +$2.38K 0.01% 716
2024
Q3 		$1.05M Buy
14,449
+7,751
+116% +$572K 0.01% 712
2024
Q2 		$449K Buy
+6,698
New +$260K 0.01% 884

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Oppenheimer Asset Management's INSM Position: Q1 2026 in Review

Oppenheimer Asset Management increased its Insmed (INSM) stake by 12% in Q1 2026, buying an estimated $242K and bringing the position to 14,725 shares worth $2.41M. The position accounts for 0.03% of the portfolio, ranked #501.

Oppenheimer Asset Management first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Oppenheimer Asset Management held 14,725 shares of Insmed worth $2.41M as of Q1 2026.
  • Oppenheimer Asset Management bought 1,574 Insmed shares in Q1 2026, an estimated $242K.
  • Insmed made up 0.03% of Oppenheimer Asset Management's portfolio in Q1 2026, its #501 holding.
  • Oppenheimer Asset Management first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.